# Aragon Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aragon-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Website: www.aragonpharmaceuticals.com
- Total disclosed funding: $104M
- Latest round: Series D (Aug 2, 2012)
- Investors on record: 5

## About

Aragon Pharmaceuticals is based in San Diego and operates as a biopharmaceutical company that develops small-molecule drugs for the treatment of hormone-dependent cancers, such as prostate and breast cancer.

## Funding rounds

- Series D, Aug 2, 2012, $50M — OrbiMed Advisors, Aisling Capital, The Column Group, Topspin Partners, VenBio
- Series C, Mar 6, 2012, $38M — OrbiMed Advisors, Aisling Capital, The Column Group, Topspin Partners
- Series B, Apr 22, 2010, $12M — OrbiMed Advisors, Aisling Capital, The Column Group
- Series A, May 20, 2009, $4M — OrbiMed Advisors, The Column Group

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A, Series B, Series C, Series D
- The Column Group (https://capitalatlas.ai/funds/the-column-group) — Series A, Series B, Series C, Series D
- Aisling Capital (https://capitalatlas.ai/funds/aisling-capital) — Series B, Series C, Series D
- Topspin Partners (https://capitalatlas.ai/funds/topspin-partners) — Series C, Series D
- VenBio (https://capitalatlas.ai/funds/venbio) — Series D